Prostaglandin E2 mediates growth arrest in NFS-60 cells by down-regulating interleukin-6 receptor expression

Biochemical Journal

Volumn 370, Issue 1, 2003, Pages 315-321

  De Silva, Kumudika I ^a   Daud, Asif N ^a   Deng, JiangPing ^a   Jones, Stephen B ^a   Gamelli, Richard L ^a   Shankar, Ravi ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Myelopoiesis; Promyelocytic cell; Sepsis

Indexed keywords

GROWTH KINETICS; IMMUNOLOGY; PROTEINS; RNA;

THERMAL INJURY;

CELLS;

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; BUTAPROST; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; STAT3 PROTEIN; SULPROSTONE; PRIMER DNA;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GROWTH DISORDER; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL DIVISION; CELL LINE; GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; DINOPROSTONE; DNA PRIMERS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MICE; RECEPTORS, INTERLEUKIN-6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037440562     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021512     Document Type: Article

References (47)

1. Chaudry, I. H. (1999) Sepsis: lessons learned in the last century and future directions. Arch. Surg. 134, 922-929
2. Gullo, A. (1999) Sepsis and organ dysfunction/failure. An overview. Minerva Anestesiol. 65, 529-540
3. Bone, R. C. (1994) Sepsis and its complications: the clinical problem. Crit. Care Med. 22, S8-S11
4. van der Poll, T. and van Deventer, S. J. (1999) Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13, 413-426
5. Terregino, C. A., Lopez, B. L., Karras, D. J., Killian, A. J. and Arnold, G. K. (2000) Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death? Ann. Emerg. Med. 35, 26-34
6. Presterl, E., Staudinger, T., Pettermann, M., Lassnigg, A., Burgmann, H., Winkler, S., Frass, M. and Graninger, W. (1997) Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am. J. Respir. Crit. Care Med. 156, 825-832
7. Schluter, B., Konig, B., Bergmann, U., Muller, F. E. and Konig, W. (1991) Interleukin 6 - a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J. Trauma 31, 1663-1670
8. Guo, Y., Dickerson, C., Chrest, F. J., Adler, W. H., Munster, A. M. and Winchurch, R. A. (1990) Increased levels of circulating interleukin 6 in burn patients. Clin. Immunol. Immunopathol. 54, 361-371
9. Ueyama, M., Maruyama, I., Osame, M. and Sawada, Y. (1992) Marked increase in plasma interleukin-6 in burn patients. J. Lab. Clin. Med. 120, 693-698
10. Nijsten, M. W., Hack, C. E., Helle, M., ten Duis, H. J., Klasen, H. J. and Aarden, L. A. (1991) Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109 761-767
11. Kishimoto, T. (1989) The biology of interleukin-6. Blood 74, 1-10
12. Liu, F., Poursine-Laurent, J., Wu, H. Y. and Link, D. C. (1997) Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90, 2583-2590
13. Santangelo, S., Gamelli, R. L. and Shankar, R. (2001) Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg. 233, 97-106
14. Shoup, M., Weisenberger, J. M., Wang, J. L., Pyle, J. M., Gamelli, R. L. and Shankar, R. (1998) Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann. Surg. 228, 112-122
15. Santangelo, S., Shoup, M., Gamelli, R. L. and Shankar, R. (2000) Prostaglandin E2 receptor antagonist (SC-19220) treatment restores the balance to bone marrow myelopoiesis after burn sepsis. J. Trauma 48, 826-830; discussion 830-831
16. Anastassiou, E. D., Paliogianni, F., Balow, J. P., Yamada, H. and Boumpas, D. T. (1992) Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J. Immunol. 148, 2845-2852
17. Brown, D. M. and Phipps, R. P. (1997) Prostaglandin E2 mediated apoptosis in subsets of malignant B lymphoma cells. Acv. Exp. Med. Biol. 400B, 565-570
18. Goodwin, J. S., Bankhurst, A. D. and Messner, R. P. (1977) Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J. Exp. Med. 146, 1719-1734
19. Hoshi, S., Furutani-Seiki, M., Seto, M., Tada, T. and Asano, Y. (1994) Prevention of TCR-mediated apoptosis by the elevation of cAMP. Int. Immunol. 6, 1081-1089
20. Gurlo, T., Huang, W. W. and von Grafensten, H. (1998) PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells. Cytokine 10, 265-274
21. Kurland, J. and Moore, M. A. (1977) Modulation of hemopoiesis by prostaglandins. Exp. Hematol. 5, 357-373
22. Pelus, L. M. and Gentile, P. S. (1988) In vivo modulation of myelopoiesis by prostaglandin E2. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation. Blood 71, 1633-1640
23. Pelus, L. M., Broxmeyer, H. E., Kurland, J. I. and Moore, M. A. (1979) Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J. Exp. Med. 150, 277-292
24. Gentile, P., Byer, D. and Pelus, L. M. (1983) In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Blood 62, 1100-1107
25. Takayarna, T. K., Miller, C. and Szabo, G. (1990) Elevated tumor necrosis factor alpha production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes. Arch. Surg. 125, 29-35
26. Ninnemann, J. L. and Stockland, A. E. (1934) Participation of prostaglandin E in immunosuppression following thermal injury. J. Trauma 24, 201-207
27. Fukushima, R., Alexander, J. W., Wu, J. Z., Mao, J. X., Szczur, K., Stephens, A. M., Ogle, J. D. and Ogle, C. K. (1994) Time course of production of cytokines and prostaglandin E2 by macrophages isolated after thermal injury and bacterial translocation. Circ. Shock 42, 154-162
28. Huribal, M., Cunningham, M. E., D'Aiuto, M. L., Pleban, W. E. and McMillen, M. A. (1995) Endothelin-1 and prostaglandin E2 levels increase in patients with burns. J. Am. Coll. Surg. 180, 318-322
29. Cory, A. H., Owen, T. C., Barltrop, J. A. and Cory, J. G. (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3, 207-212
30. Zeng, L., An, S. and Goetzl, E. J. (1996) Regulation of expression of matrix metalloproteinase-9 in early human-T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. J. Biol. Chem. 271, 27744-27750
31. Schreiber, E., Matthias, P., Muller, M. M. and Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419
32. Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M. T., Mannon, R., Koller, B. H. and Coffman, T. M. (2001) Receptors for proslaglandin E(2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229-1235
33. Negishi, M., Sugimoto, Y. and Ichikawa, A. (1995) Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1259, 109-119
34. Vairo, G., Argyriou, S., Bordun, A. M., Whitty, G. and Hamilton, J. A. (1990) Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to colony stimulating factor-1. J. Biol. Chem. 265, 2692-2701
35. Ward, A. C., Hoffmann, B. W., Csar, X. F. and Hamilton, J. A. (1996) Granulocyte colony-stimulating factor-stimulated proliferation of myeloid cells: mode of cell cycle control by a range of inhibitors. J. Interferon Cytokine Res. 16, 869-877
36. Struzyna, J., Pojda, Z., Braun, B., Chomicka, M., Sobiczewska, E. and Wrembel, J. (1995) Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns 21, 437-440
37. Shoup, M., He, L. K., Liu, H., Shankar, R. and Gamelli, R. (1998) Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection. J. Trauma 45, 215-220; discussion 220-221
38. Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F. and Graeve, L. (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314
39. Rincon, M., Tugores, A., Lopez-Rivas, A., Silva, A., Alonso, M., De Landazuri, M. O. and Lopez-Botet, M. (1988) Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur. J. Immunol. 18, 1791-1796
40. Hume, D. A., Allan, W., Fabrus, B., Weidemann, M. J., Hapel, A. J. and Bartelmez, S. (1987) Regulation of proliferation of bone marrow-derived macrophages. Lymphokine Res. 6, 127-139
41. Ward, A. C., Csar, X. F., Hoffmann, B. W. and Hamilton, J. A. (1996) Cyclic AMP inhibits expression of D-type cyclins and cdk4 and induces p27Kip1 in G-CSF-treated NFS-60 cells Biochem. Biophys. Res. Commun. 224, 10-16
42. Horgan, A. F., O'Riordain, D. S., Chin, D. H., Mannick, J. A. and Rodrick, M. L. (1994) The role of cyclic adenosine monophosphate in the suppression of cellular immunity after thermal injury. Arch. Surg. 129, 1284-1289
43. 1 stage of the cell cycle and overrides constitutive c-myc expression. Mol. Cell. Biol. 12, 2351-2358
44. Stewart, A. G., Harris, T., Fernandes, D. J., Schachte, L. C., Koutsoubos, V., Guida, E., Ravenhall, C. E., Vadiveloo, P. and Wilson, J. W. (1999) Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1. Mol. Pharmacol. 56, 1079-1086
45. Suzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S. and Suda, T. (2000) The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141, 1554-1559
46. Miyaura, C., Inada, M., Suzawa, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S. and Suda, T. (2000) Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J Biol. Chem. 275, 19819-19823
47. Hubbard, N. E., Lee, S., Lim, D. and Erickson, K. L. (2001) Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation. Prostaglandins Leukot. Essent. Fatty Acids 65, 287-294